AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. GTBP
  4. [EFFECT] GT Biopharma Inc. SEC Filing

[EFFECT] GT Biopharma Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 5:00 P.M.
Form: S-1
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-287963

Source:

Stock GTBP logo
Gt Biopharma Inc

NASDAQ:GTBP

GTBP Rankings

#6231 Ranked by Market Cap
N/A Ranked by Dividends
#57 Top Loser

GTBP Latest News

Aug 14, 2025
GT Biopharma Reports Second Quarter 2025 Financial Results
Aug 11, 2025
GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2
Jun 13, 2025
GT Biopharma Appoints New Member to its Board of Directors
May 19, 2025
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
May 15, 2025
GT Biopharma Appoints New Member to its Board of Directors

GTBP Latest SEC Filings

Jul 30, 2025
[Form 3] GT Biopharma Inc. Initial Statement of Beneficial Ownership
Jul 24, 2025
[8-K] GT Biopharma Inc. Reports Material Event
Jul 3, 2025
[424B3] GT Biopharma Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 27, 2025
[S-1/A] GT Biopharma Inc. Amends IPO Registration Statement

GTBP Stock Data

5.73M
2.54M
22.28%
13.45%
8.36%
Biotechnology
Pharmaceutical Preparations
United States
SAN FRANCISCO